Frontiers in Immunology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2023-06-13 超级敏感型来自北京

请问纯生信的还接收吗

63 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2024-04-11 ms1000001490330585 来自广东省

Initial Validation 一周了，有一样的同学吗

148 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2021-05-06 H·D·E

这个杂志开始要求提供原始数据了，不然过不了质检

177 69

展开69条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2024-03-26 气管支气管来自江西省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：免疫;肿瘤
经验分享：Received date: 12 Dec 2023
Editorial assignment start date: 13 Dec 2023
Independent review start date: 02 Jan 2024
Interactive review activated date: 19 Jan 2024
Review finalized date: 22 Mar 2024
Final validation date: 25 Mar 2024
同日接收

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2023-05-22 小菲DMU 来自辽宁省

偏重的研究方向：生信
经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？

109 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2024-03-23 18846913243 来自黑龙江省

审稿速度:3.0 | 投稿命中率:25.0
经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦

20 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2024-01-22 ms3000001773627036 来自广东省

偏重的研究方向：免疫
经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗

49 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2024-03-13 ms7991353960699732 来自河南省

偏重的研究方向：生信免疫;免疫;生信
经验分享：非肿瘤纯生信秒拒

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2023-06-02 ms6000000562901411 来自四川省

偏重的研究方向：生物信息学;肿瘤
经验分享：想请问一下生物信息学投这个杂志的文章类型是什么

65 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142575, encodeId=bd9a21425e5e3, content=请问纯生信的还接收吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fc465505038, createdName=超级敏感型, createdTime=Tue Jun 13 15:58:34 CST 2023, time=2023-06-13, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198035, encodeId=107d219803514, content=Initial Validation 一周了，有一样的同学吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9675507809, createdName=ms1000001490330585, createdTime=Thu Apr 11 21:42:13 CST 2024, time=2024-04-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=963204, encodeId=af5296320464, content=这个杂志开始要求提供原始数据了，不然过不了质检, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=177, replyNumber=69, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/AC155882450E4EC1FD036F717D37D497/100, createdBy=ba642497095, createdName=H·D·E, createdTime=Thu May 06 20:48:02 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2195473, encodeId=fbbb21954e364, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤 经验分享：Received date: 12 Dec 2023 Editorial assignment start date: 13 Dec 2023 Independent review start date: 02 Jan 2024 Interactive review activated date: 19 Jan 2024 Review finalized date: 22 Mar 2024 Final validation date: 25 Mar 2024 同日接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f4c5506339, createdName=气管支气管, createdTime=Tue Mar 26 17:06:59 CST 2024, time=2024-03-26, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2138388, encodeId=9c6b2138388d3, content=偏重的研究方向：生信 经验分享：求问大佬，投稿之后这个 Initial Validation已经第五个工作日了还没进展也没回信，这个正常吗?我看上面写的一般1-3天，发邮件问说继续等着就行?我看还有一个提示是Edited by: No Associate Editor assigned.和这个有关嘛？还是继续等着就行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/06/15/8ab6ec2e28caa8e1610486df551c764a.jpg, createdBy=27c22076284, createdName=小菲DMU, createdTime=Mon May 22 14:17:07 CST 2023, time=2023-05-22, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2194877, encodeId=40dc21948e7d4, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：文章先投了frontiers的另外一个杂志被拒绝后推荐我其他杂志，有一键转投的按钮，我就转投了。但是临时需要加一个共同通讯。一直在和杂志联系，未果。之后文章被接收了，版面费也打过去了，而且出了排版，排版里面确实把共同通讯加进去了，但是杂志社发邮件让我提供证明，但是我提供了多次证明后，杂志社不给回复。突然通知我拒稿。我感觉很无语，这两天把版面费返给我了。如果不同意加共同通讯，那告诉我一下啊，我和导师商量一下。这下影响我毕业了。真烦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de05533346, createdName=18846913243, createdTime=Sat Mar 23 17:13:12 CST 2024, time=2024-03-23, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2183172, encodeId=a2b121831e220, content=偏重的研究方向：免疫 经验分享：6天还在EA，没有分配编辑，孟德尔有人投过吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db358224281, createdName=ms3000001773627036, createdTime=Mon Jan 22 12:27:32 CST 2024, time=2024-01-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2192895, encodeId=2bd6219289581, content=偏重的研究方向：生信免疫;免疫;生信 经验分享：非肿瘤纯生信秒拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 13 08:51:56 CST 2024, time=2024-03-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2140407, encodeId=eeb9214040eab, content=偏重的研究方向：生物信息学;肿瘤 经验分享：想请问一下生物信息学投这个杂志的文章类型是什么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0ea66481946, createdName=ms6000000562901411, createdTime=Fri Jun 02 00:15:33 CST 2023, time=2023-06-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2190171, encodeId=0a3421901e188, content=偏重的研究方向：结直肠癌 经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f329192706, createdName=ms9000000568355466, createdTime=Thu Feb 29 19:27:56 CST 2024, time=2024-02-29, status=1, ipAttribution=河南省)]

2024-02-29 ms9000000568355466 来自河南省

偏重的研究方向：结直肠癌
经验分享：我发了一篇文献计量学的文章被秒拒，理由是什么诚信，政策问题，完全不知道什么问题

23 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务